ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

0G8X Immunovia Ab (publ)

191,40
0,00 (0,00%)
24 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Immunovia Ab (publ) 0G8X London Ordinary Share
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 191,40 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
191,40 191,40
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.1.202416:59PRNUSImmunovia announces financial calendar for financial year..
04.1.202416:58PRNUSImmunovia announces financial calendar for financial year..
21.11.202311:40PRNUSBulletin from the extraordinary general meeting in Immunovia..
21.11.202311:38PRNUSBulletin from the extraordinary general meeting in Immunovia..
09.11.202309:03PRNUSImmunovia Publishes Interim Report for January-September..
09.11.202308:59PRNUSImmunovia Publishes Interim Report for January-September..
07.11.202316:14PRNUSImmunovia successfully completes discovery phase of..
07.11.202316:12PRNUSImmunovia successfully completes discovery phase of..
02.11.202311:02PRNUSInvitation to Immunovia's Q3 presentation
02.11.202311:00PRNUSInvitation to Immunovia's Q3 presentation
27.10.202309:06PRNUSCONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN..
27.10.202309:03PRNUSCONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN..
03.10.202311:01PRNUSNomination Committee appointed for Immunovia AB (Publ)
03.10.202310:56PRNUSNomination Committee appointed for Immunovia AB (Publ)
30.8.202312:30PRNUSImmunovia Publishes Interim Report for January-June 2023
30.8.202308:56PRNUSImmunovia Publishes Interim Report for January-June 2023
23.8.202320:08PRNUSInvitation to Immunovia's Q2 presentation
23.8.202320:06PRNUSInvitation to Immunovia's Q2 presentation
19.7.202318:47PRNUSImmunovia announces updated financial calendar
12.7.202309:15PRNUSImmunovia to Significantly Restructure to Focus Resources on..
12.7.202309:12PRNUSImmunovia to Significantly Restructure to Focus Resources on..
09.6.202310:19PRNUSChief Executive Officer, Jeff Borcherding, buys Immunovia..
09.6.202310:11PRNUSChief Executive Officer, Jeff Borcherding, buys Immunovia..
31.5.202312:16PRNUSChange in number of shares and votes in Immunovia AB (publ)
31.5.202312:13PRNUSChange in number of shares and votes in Immunovia AB (publ)
26.5.202313:43PRNUSBulletin from the Annual General Meeting in Immunovia AB
26.5.202313:41PRNUSBulletin from the Annual General Meeting in Immunovia AB
23.5.202309:03PRNUSImmunovia Publishes Interim Report for January-March 2023
23.5.202309:00PRNUSImmunovia Publishes Interim Report for January-March 2023
22.5.202318:55PRNUSChanges to the Nomination Committee's proposal to the Annual..
22.5.202318:51PRNUSChanges to the Nomination Committee's proposal to the Annual..
17.5.202310:43PRNUSInvitation to Immunovia's Q1 presentation
17.5.202310:41PRNUSInvitation to Immunovia's Q1 presentation
06.5.202313:40PRNUSThe board member Philipp von Hugo resigns from Immunovia's..
30.4.202312:17PRNUSImmunovia AB appoints new CEO
30.4.202312:15PRNUSImmunovia AB appoints new CEO
26.4.202314:44PRNUSImmunovia to discuss adoption of IMMray™ PanCan-d with key..
26.4.202314:42PRNUSImmunovia to discuss adoption of IMMray™ PanCan-d with key..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock